Najnowsze artykuły: What the FDA’s High-Dose Nusinersen Approval Means for Drug DevelopmentThe FDA approved a high-dose nusinersen regimen for spinal muscular atrophy, offering pharma teams key insights into dose optimization and lifecycle management. The FDA has approved a high-dose ...